Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

FHS
June 23, 2023
5:26 am

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

Medicxi backs Chinese biotech’s next-gen KRAS G12C drug with $40M injection

The search for next-generation KRAS drugs that can do what Amgen and Bristol Myers Squibb’s medicines can’t has led to Medicxi’s first-ever investment in China.

April 9, 2024

4P-Pharma raises €15M; Oncotelic Therapeutics sells rights to cancer assets

Plus, news about Adaptilens: 4P-Pharma secures €15M in second closing: The fundraise, which was backed by private investors, will be used to support the French biotech as

April 30, 2024

Combined marijuana and cigarette smoking may increase lung damage

Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs, according to research being presented today at the annual

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.